From: Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis
Markera | Median | Range | P b | AUC (95% CI) |
---|---|---|---|---|
MMP-1 (pg/mL) | ||||
Control | 6209.72 | 935.32–23,960.37 | 0.364 | 0.538 (0.457–0.620) |
Healthy | 4730.11 | 1081.81–23,635.33 | 0.045 | |
Benign | 7483.33 | 935.32–23,960.37 | 0.974 | |
NSCLC | 6653.85 | 1450.34–41,668.33 | ||
NSCLC I + II | 6046.96 | 1784.41–30,180.33 | 0.772 | |
NSCLC III + IV | 6972.73 | 1450.34–41,668.33 | 0.324 | |
MMP-7 (pg/mL) | ||||
Control | 22,130.10 | 5026.14–79,977.27 | 0.014 | 0.604 (0.523–0.685) |
Healthy | 21,010.07 | 8893.61–48,743.79 | 0.004 | |
Benign | 22,739.58 | 5026.14–79,977.27 | 0.109 | |
NSCLC | 26,485.45 | 5383.18–79,809.13 | ||
NSCLC I + II | 26,165.87 | 13,727.30–54,573.51 | 0.465 | |
NSCLC III + IV | 26,680.26 | 5383.18–79,809.13 | 0.007 | |
MMP-9 (ng/mL) | ||||
Control | 194.84 | 11.07–3611.59 | <0.001 | 0.739 (0.670–0.809) |
Healthy | 177.86 | 52.79–800.30 | <0.001 | |
Benign | 200.28 | 11.07–3611.59 | <0.001 | |
NSCLC | 348.04 | 21.06–1941.08 | ||
NSCLC I + II | 346.03 | 116.92–1941.08 | 0.002 | |
NSCLC III + IV | 364.62 | 21.06–1914.00 | <0.001 |